InterCure Ltd. (INCR)

InterCure Ltd. (INCR) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $81.3M; returns 1 day +2.0%, 1 week -0.9%, 1 year -38.4%.

InterCure Ltd. is a major international pharmaceutical-grade cannabis company headquartered in Israel, operating a vertically integrated, seed-to-sale commercial business model. Through its main operating subsidiary Canndoc, the company cultivates, manufactures, imports, and distributes EU-GMP certified medical cannabis products, including dried inflorescences and oil extracts.

Groups INCR belongs to

• Recent Reverse Splits
• Israel Companies
• Cannabis
• Pharmaceuticals
• Healthcare
• Israel
• Vertical Integration

INCR financial model: income statement, cash flow and balance sheet